RESERVE: Right VEntricular Contractile ReSERVE in Functional Tricuspid Regurgitation

Sponsor
Heart Center Leipzig - University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04141683
Collaborator
(none)
108
1
41.7
2.6

Study Details

Study Description

Brief Summary

Aim of the study is to investigate the prognostic value of right ventricular contractile reserve in patients with functional tricuspid regurgitation undergoing tricuspid valve repair or replacement.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Stress Echocardiography
  • Diagnostic Test: Pressure volume loop analysis
  • Procedure: Tricuspid valve repair or replacement

Detailed Description

Chronic volume overload in patients with severe tricuspid regurgitation (TR) leads to right ventricular (RV) dilatation, fibrosis and eventually failure. RV dysfunction is an important determinant of mortality in patients undergoing tricuspid valve surgery.

Aim of the current study is to investigate the prognostic utility of right ventricular contractile reserve in patients with severe TR undergoing surgical or interventional tricuspid valve repair or tricuspid valve replacement.

RV contractile reserve will be assessed using semi-supine bicycle stress echocardiography.

Echocardiographic parameters are prone to altered loading conditions, such as volume overload. Load independent RV contractility can only be measured using invasive pressure-volume-loop (PVL) analysis. Therefore RV PVL analysis will be done using conductance catheter in a subset of patients who undergo right heart catheterization for clinical evaluation of pulmonary hypertension. Aim of this sub study is the validation of non-invasively derived RV contractile reserve with load independent markers of intrinsic RV contractility.

Study Design

Study Type:
Observational
Anticipated Enrollment :
108 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prognostic Implication of Right Ventricular Contractile Reserve in Patients With Functional Tricuspid Regurgitation
Actual Study Start Date :
Jun 10, 2019
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Death or heart failure hospitalization [6-12 month]

    Death or heart failure hospitalization according to right ventricular contractile reserve.

Secondary Outcome Measures

  1. Death [6-12 month]

    Death according to right ventricular contractile reserve.

  2. Cardiovascular Death [6-12 month]

    Cardiovascular Death according to right ventricular contractile reserve.

  3. Heart Failure Hospitalization [6-12 month]

    Heart Failure Hospitalization according to right ventricular contractile reserve.

  4. Intrinsic RV contractility [Baseline]

    Correlation of RV contractile reserve with the slope of invasively derived right ventricular end systolic elastance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Severe functional tricuspid regurgitation.

  • Planned surgical or interventional tricuspid valve repair or replacement.

  • Able to cycle on a semisupine tilting exercise table.

  • Informed consent.

Exclusion Criteria:
  • Coronary artery disease with significant ischemia.

  • Unstable Angina.

  • Myocardial infarction <4 month prior to inclusion.

  • Concomitant valvular heart disease (aortic, mitral or pulmonary valve) > mild-moderate.

  • Constrictive pericarditis.

  • Malignant disease with a life expectancy < 12 months.

  • Pregnancy.

  • Insufficient image quality on echocardiography.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Heart Center Leipzig at Leipzig University Leipzig Germany 04289

Sponsors and Collaborators

  • Heart Center Leipzig - University Hospital

Investigators

  • Principal Investigator: Philipp Lurz, MD, PhD, University of Leipzig

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Philipp Lurz, Clinical Investigator, Professor, Managing Senior Physician, Heart Center Leipzig - University Hospital
ClinicalTrials.gov Identifier:
NCT04141683
Other Study ID Numbers:
  • RESERVE
First Posted:
Oct 28, 2019
Last Update Posted:
May 10, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Philipp Lurz, Clinical Investigator, Professor, Managing Senior Physician, Heart Center Leipzig - University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2021